Litcius/Paper detail

Postoperative radiotherapy versus no postoperative radiotherapy in patients with completely resected non-small-cell lung cancer and proven mediastinal N2 involvement (Lung ART, IFCT 0503): an open-label, randomised, phase 3 trial

Cecile Le Pechoux, Nicolas Pourel, Fabrice Barlesi, Delphine Lerouge, Delphine Antoni, Bruno Lamezec, Ursula Nestle, Pierre Boisselier, Eric Dansin, Amaury Paumier, Karine Peignaux, François Thillays, Gerard Zalcman, Jeannick Madelaine, Eric Pichon, Anne Larrouy, Armelle Lavole, Delphine Argo-Leignel, Marc Derollez, Corinne Faivre-Finn, Matthew Q Hatton, Oliver Riesterer, Emilie Bouvier-Morel, Ariane Dunant, John G Edwards, Pascal Alexandre Thomas, Olaf Mercier, Aurelie Bardet

2021The Lancet Oncology264 citationsDOI

Topics & Concepts

MedicineLung cancerRadiation therapyCancerSurgeryClinical trialRespiratory diseaseEpidemiologyIncidence (geometry)Randomized controlled trialLung diseaseMEDLINEGeneral surgeryGynecologyDiseaseLung Cancer Diagnosis and TreatmentLung Cancer Research StudiesLung Cancer Treatments and Mutations
Postoperative radiotherapy versus no postoperative radiotherapy in patients with completely resected non-small-cell lung cancer and proven mediastinal N2 involvement (Lung ART, IFCT 0503): an open-label, randomised, phase 3 trial | Litcius